Form 4 for IBO IMPACT BIOMEDICAL INC.
Accepted 2025-03-28 00:00:00 ET · period of report 2025-03-21 · accession 0001641172-25-001312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-03-28 | 2025-03-21 | IBO | DSS, INC. | 10% | S - Sale | $3.30 | -499.8K | 1.18M | -30% | -$1.65M |
| M | 2025-03-28 | 2025-03-26+ | IBO | DSS, INC. | 10% | S - Sale | $2.85 | -105.8K | 1.10M | -9% | -$301.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-21 | S | D | 166,600 | $3.30 | 0 | I By DSS Securities, Inc. | — | — | (F1) This entity is a wholly-owned subsidiary of DSS, Inc. |
| 2 | Common | Common Stock | 2025-03-21 | S | D | 166,600 | $3.30 | 0 | I By DSS BlockChain Security, Inc. | — | — | (F1) This entity is a wholly-owned subsidiary of DSS, Inc. |
| 3 | Common | Common Stock | 2025-03-27 | S | D | 47,681 | $2.50 | 1,051,800 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-26 | S | D | 48,281 | $3.13 | 1,109,339 | D | — | — | |
| 5 | Common | Common Stock | 2025-03-26 | S | D | 9,858 | $3.15 | 1,099,481 | D | — | — | |
| 6 | Common | Common Stock | 2025-03-21 | S | D | 166,600 | $3.30 | 1,178,882 | I By DSS BioHealth Security, Inc. | — | — | (F1) This entity is a wholly-owned subsidiary of DSS, Inc. |